Table 1 Inclusion and exclusion criteria

Inclusion criteria

 History of MI according to guidelines:

  CHA₂DS₂-VASc score ≥ 4 in men/≥ 5 in women

  LVEF > 35% as estimated within 6 months before enrollment but after conclusion of acute MI treatment

  Patient accepts activation of home monitoring

  Patient has provided written informed consent

Exclusion criteria

 Platelet count < 90,000 per mm³ or patients with hemorrhagic diathesis

 Permanent oral anticoagulation treatment for atrial fibrillation

 Indication for chronic renal dialysis

 Pacemaker or ICD implanted or indication for implantation

 Parkinson’s disease

 Life expectancy < 1 year

 Participation in another interventional clinical investigation during the course of the study, i.e. the participation in a noninterventional clinical investigation is allowed.

 Age < 18 years

 Woman who are pregnant or breast feeding